 | • レポートコード：QYR2104Z1066 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍溶解性ウイルス療法、遺伝子導入、遺伝子誘導免疫療法）、用途別市場規模（病院、診断センター、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん遺伝子治療の市場動向 ・企業の競争状況、市場シェア ・がん遺伝子治療の種類別市場規模（腫瘍溶解性ウイルス療法、遺伝子導入、遺伝子誘導免疫療法） ・がん遺伝子治療の用途別市場規模（病院、診断センター、研究機関） ・がん遺伝子治療の北米市場規模2016-2027（アメリカ、カナダ） ・がん遺伝子治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん遺伝子治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん遺伝子治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん遺伝子治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Adaptimmune、Bluebird bio、Celgene、Shanghai Sunway Biotech、Shenzhen SiBiono GeneTech、SynerGene Therapeutics、Altor BioScience、Amgen、Argenx、BioCancell、GlaxoSmithKline、Merck、OncoGenex Pharmaceuticals、Transgene） ・結論 |
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.
Market Analysis and Insights: Global Cancer Gene Therapy Market
The global Cancer Gene Therapy market size is projected to reach US$ 1657.7 million by 2026, from US$ 522 million in 2019, at a CAGR of 17.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Gene Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Gene Therapy market.
Global Cancer Gene Therapy Scope and Market Size
Cancer Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Segment by Application
Hospitals
Diagnostics Centers
Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
Merck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oncolytic Virotherapy
1.2.3 Gene Transfer
1.2.4 Gene-Induced Immunotherapy
1.3 Market by Application
1.3.1 Global Cancer Gene Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Gene Therapy Market Perspective (2016-2027)
2.2 Cancer Gene Therapy Growth Trends by Regions
2.2.1 Cancer Gene Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Gene Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Gene Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Gene Therapy Industry Dynamic
2.3.1 Cancer Gene Therapy Market Trends
2.3.2 Cancer Gene Therapy Market Drivers
2.3.3 Cancer Gene Therapy Market Challenges
2.3.4 Cancer Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Gene Therapy Players by Revenue
3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2016-2021)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Gene Therapy Revenue
3.4 Global Cancer Gene Therapy Market Concentration Ratio
3.4.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2020
3.5 Cancer Gene Therapy Key Players Head office and Area Served
3.6 Key Players Cancer Gene Therapy Product Solution and Service
3.7 Date of Enter into Cancer Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Gene Therapy Breakdown Data by Type
4.1 Global Cancer Gene Therapy Historic Market Size by Type (2016-2021)
4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2022-2027)
5 Cancer Gene Therapy Breakdown Data by Application
5.1 Global Cancer Gene Therapy Historic Market Size by Application (2016-2021)
5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Gene Therapy Market Size (2016-2027)
6.2 North America Cancer Gene Therapy Market Size by Type
6.2.1 North America Cancer Gene Therapy Market Size by Type (2016-2021)
6.2.2 North America Cancer Gene Therapy Market Size by Type (2022-2027)
6.2.3 North America Cancer Gene Therapy Market Size by Type (2016-2027)
6.3 North America Cancer Gene Therapy Market Size by Application
6.3.1 North America Cancer Gene Therapy Market Size by Application (2016-2021)
6.3.2 North America Cancer Gene Therapy Market Size by Application (2022-2027)
6.3.3 North America Cancer Gene Therapy Market Size by Application (2016-2027)
6.4 North America Cancer Gene Therapy Market Size by Country
6.4.1 North America Cancer Gene Therapy Market Size by Country (2016-2021)
6.4.2 North America Cancer Gene Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Gene Therapy Market Size (2016-2027)
7.2 Europe Cancer Gene Therapy Market Size by Type
7.2.1 Europe Cancer Gene Therapy Market Size by Type (2016-2021)
7.2.2 Europe Cancer Gene Therapy Market Size by Type (2022-2027)
7.2.3 Europe Cancer Gene Therapy Market Size by Type (2016-2027)
7.3 Europe Cancer Gene Therapy Market Size by Application
7.3.1 Europe Cancer Gene Therapy Market Size by Application (2016-2021)
7.3.2 Europe Cancer Gene Therapy Market Size by Application (2022-2027)
7.3.3 Europe Cancer Gene Therapy Market Size by Application (2016-2027)
7.4 Europe Cancer Gene Therapy Market Size by Country
7.4.1 Europe Cancer Gene Therapy Market Size by Country (2016-2021)
7.4.2 Europe Cancer Gene Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Gene Therapy Market Size (2016-2027)
8.2 Asia-Pacific Cancer Gene Therapy Market Size by Type
8.2.1 Asia-Pacific Cancer Gene Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Gene Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Gene Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Gene Therapy Market Size by Application
8.3.1 Asia-Pacific Cancer Gene Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Gene Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Gene Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Gene Therapy Market Size by Region
8.4.1 Asia-Pacific Cancer Gene Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Gene Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Gene Therapy Market Size (2016-2027)
9.2 Latin America Cancer Gene Therapy Market Size by Type
9.2.1 Latin America Cancer Gene Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Gene Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Gene Therapy Market Size by Type (2016-2027)
9.3 Latin America Cancer Gene Therapy Market Size by Application
9.3.1 Latin America Cancer Gene Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Gene Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Gene Therapy Market Size by Application (2016-2027)
9.4 Latin America Cancer Gene Therapy Market Size by Country
9.4.1 Latin America Cancer Gene Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Gene Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Gene Therapy Market Size (2016-2027)
10.2 Middle East & Africa Cancer Gene Therapy Market Size by Type
10.2.1 Middle East & Africa Cancer Gene Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Gene Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Gene Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Gene Therapy Market Size by Application
10.3.1 Middle East & Africa Cancer Gene Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Gene Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Gene Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Gene Therapy Market Size by Country
10.4.1 Middle East & Africa Cancer Gene Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Gene Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Cancer Gene Therapy Introduction
11.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2016-2021)
11.1.5 Adaptimmune Recent Development
11.2 Bluebird bio
11.2.1 Bluebird bio Company Details
11.2.2 Bluebird bio Business Overview
11.2.3 Bluebird bio Cancer Gene Therapy Introduction
11.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2016-2021)
11.2.5 Bluebird bio Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Cancer Gene Therapy Introduction
11.3.4 Celgene Revenue in Cancer Gene Therapy Business (2016-2021)
11.3.5 Celgene Recent Development
11.4 Shanghai Sunway Biotech
11.4.1 Shanghai Sunway Biotech Company Details
11.4.2 Shanghai Sunway Biotech Business Overview
11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
11.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2016-2021)
11.4.5 Shanghai Sunway Biotech Recent Development
11.5 Shenzhen SiBiono GeneTech
11.5.1 Shenzhen SiBiono GeneTech Company Details
11.5.2 Shenzhen SiBiono GeneTech Business Overview
11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
11.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2016-2021)
11.5.5 Shenzhen SiBiono GeneTech Recent Development
11.6 SynerGene Therapeutics
11.6.1 SynerGene Therapeutics Company Details
11.6.2 SynerGene Therapeutics Business Overview
11.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
11.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2016-2021)
11.6.5 SynerGene Therapeutics Recent Development
11.7 Altor BioScience
11.7.1 Altor BioScience Company Details
11.7.2 Altor BioScience Business Overview
11.7.3 Altor BioScience Cancer Gene Therapy Introduction
11.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2016-2021)
11.7.5 Altor BioScience Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Cancer Gene Therapy Introduction
11.8.4 Amgen Revenue in Cancer Gene Therapy Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 Argenx
11.9.1 Argenx Company Details
11.9.2 Argenx Business Overview
11.9.3 Argenx Cancer Gene Therapy Introduction
11.9.4 Argenx Revenue in Cancer Gene Therapy Business (2016-2021)
11.9.5 Argenx Recent Development
11.10 BioCancell
11.10.1 BioCancell Company Details
11.10.2 BioCancell Business Overview
11.10.3 BioCancell Cancer Gene Therapy Introduction
11.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2016-2021)
11.10.5 BioCancell Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
11.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Cancer Gene Therapy Introduction
11.12.4 Merck Revenue in Cancer Gene Therapy Business (2016-2021)
11.12.5 Merck Recent Development
11.13 OncoGenex Pharmaceuticals
11.13.1 OncoGenex Pharmaceuticals Company Details
11.13.2 OncoGenex Pharmaceuticals Business Overview
11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
11.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2016-2021)
11.13.5 OncoGenex Pharmaceuticals Recent Development
11.14 Transgene
11.14.1 Transgene Company Details
11.14.2 Transgene Business Overview
11.14.3 Transgene Cancer Gene Therapy Introduction
11.14.4 Transgene Revenue in Cancer Gene Therapy Business (2016-2021)
11.14.5 Transgene Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oncolytic Virotherapy
Table 3. Key Players of Gene Transfer
Table 4. Key Players of Gene-Induced Immunotherapy
Table 5. Global Cancer Gene Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cancer Gene Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Gene Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cancer Gene Therapy Market Share by Regions (2016-2021)
Table 9. Global Cancer Gene Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cancer Gene Therapy Market Share by Regions (2022-2027)
Table 11. Cancer Gene Therapy Market Trends
Table 12. Cancer Gene Therapy Market Drivers
Table 13. Cancer Gene Therapy Market Challenges
Table 14. Cancer Gene Therapy Market Restraints
Table 15. Global Cancer Gene Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cancer Gene Therapy Market Share by Players (2016-2021)
Table 17. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Gene Therapy as of 2020)
Table 18. Ranking of Global Top Cancer Gene Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Gene Therapy Product Solution and Service
Table 22. Date of Enter into Cancer Gene Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cancer Gene Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cancer Gene Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cancer Gene Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cancer Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cancer Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cancer Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cancer Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cancer Gene Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cancer Gene Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cancer Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cancer Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cancer Gene Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cancer Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cancer Gene Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cancer Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cancer Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cancer Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Adaptimmune Company Details
Table 63. Adaptimmune Business Overview
Table 64. Adaptimmune Cancer Gene Therapy Product
Table 65. Adaptimmune Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 66. Adaptimmune Recent Development
Table 67. Bluebird bio Company Details
Table 68. Bluebird bio Business Overview
Table 69. Bluebird bio Cancer Gene Therapy Product
Table 70. Bluebird bio Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 71. Bluebird bio Recent Development
Table 72. Celgene Company Details
Table 73. Celgene Business Overview
Table 74. Celgene Cancer Gene Therapy Product
Table 75. Celgene Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 76. Celgene Recent Development
Table 77. Shanghai Sunway Biotech Company Details
Table 78. Shanghai Sunway Biotech Business Overview
Table 79. Shanghai Sunway Biotech Cancer Gene Therapy Product
Table 80. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 81. Shanghai Sunway Biotech Recent Development
Table 82. Shenzhen SiBiono GeneTech Company Details
Table 83. Shenzhen SiBiono GeneTech Business Overview
Table 84. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
Table 85. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 86. Shenzhen SiBiono GeneTech Recent Development
Table 87. SynerGene Therapeutics Company Details
Table 88. SynerGene Therapeutics Business Overview
Table 89. SynerGene Therapeutics Cancer Gene Therapy Product
Table 90. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 91. SynerGene Therapeutics Recent Development
Table 92. Altor BioScience Company Details
Table 93. Altor BioScience Business Overview
Table 94. Altor BioScience Cancer Gene Therapy Product
Table 95. Altor BioScience Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 96. Altor BioScience Recent Development
Table 97. Amgen Company Details
Table 98. Amgen Business Overview
Table 99. Amgen Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 100. Amgen Recent Development
Table 101. Argenx Company Details
Table 102. Argenx Business Overview
Table 103. Argenx Cancer Gene Therapy Product
Table 104. Argenx Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 105. Argenx Recent Development
Table 106. BioCancell Company Details
Table 107. BioCancell Business Overview
Table 108. BioCancell Cancer Gene Therapy Product
Table 109. BioCancell Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 110. BioCancell Recent Development
Table 111. GlaxoSmithKline Company Details
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Cancer Gene Therapy Product
Table 114. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 115. GlaxoSmithKline Recent Development
Table 116. Merck Company Details
Table 117. Merck Business Overview
Table 118. Merck Cancer Gene Therapy Product
Table 119. Merck Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 120. Merck Recent Development
Table 121. OncoGenex Pharmaceuticals Company Details
Table 122. OncoGenex Pharmaceuticals Business Overview
Table 123. OncoGenex Pharmaceuticals Cancer Gene Therapy Product
Table 124. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 125. OncoGenex Pharmaceuticals Recent Development
Table 126. Transgene Company Details
Table 127. Transgene Business Overview
Table 128. Transgene Cancer Gene Therapy Product
Table 129. Transgene Revenue in Cancer Gene Therapy Business (2016-2021) & (US$ Million)
Table 130. Transgene Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Gene Therapy Market Share by Type: 2020 VS 2027
Figure 2. Oncolytic Virotherapy Features
Figure 3. Gene Transfer Features
Figure 4. Gene-Induced Immunotherapy Features
Figure 5. Global Cancer Gene Therapy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Diagnostics Centers Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Cancer Gene Therapy Report Years Considered
Figure 10. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cancer Gene Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cancer Gene Therapy Market Share by Regions: 2020 VS 2027
Figure 13. Global Cancer Gene Therapy Market Share by Regions (2022-2027)
Figure 14. Global Cancer Gene Therapy Market Share by Players in 2020
Figure 15. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Gene Therapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2020
Figure 17. Global Cancer Gene Therapy Revenue Market Share by Type (2016-2021)
Figure 18. Global Cancer Gene Therapy Revenue Market Share by Type (2022-2027)
Figure 19. North America Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cancer Gene Therapy Market Share by Type (2016-2027)
Figure 21. North America Cancer Gene Therapy Market Share by Application (2016-2027)
Figure 22. North America Cancer Gene Therapy Market Share by Country (2016-2027)
Figure 23. United States Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Gene Therapy Market Share by Type (2016-2027)
Figure 27. Europe Cancer Gene Therapy Market Share by Application (2016-2027)
Figure 28. Europe Cancer Gene Therapy Market Share by Country (2016-2027)
Figure 29. Germany Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Gene Therapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cancer Gene Therapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cancer Gene Therapy Market Share by Region (2016-2027)
Figure 39. China Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Gene Therapy Market Share by Type (2016-2027)
Figure 47. Latin America Cancer Gene Therapy Market Share by Application (2016-2027)
Figure 48. Latin America Cancer Gene Therapy Market Share by Country (2016-2027)
Figure 49. Mexico Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Gene Therapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cancer Gene Therapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cancer Gene Therapy Market Share by Country (2016-2027)
Figure 55. Turkey Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cancer Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 59. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 60. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 61. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 62. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 63. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 64. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 66. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 67. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 68. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 70. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 71. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …- 世界のがん遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression. Market Analysis and Insights: Global Gene Therapy For Cancer Market The global Gene Therapy For Cancer market size is projected to …
- 世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 世界の遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…
- 世界のムコ多糖症遺伝子治療市場規模・現状・予測（2021年-2027年） Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …